Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ainos Inc (NQ: AIMD )

0.5749 -0.0250 (-4.17%)
Streaming Delayed Price Updated: 10:19 AM EST, Dec 4, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,458
Open 0.5998
Bid (Size) 0.5748 (4)
Ask (Size) 0.5998 (20)
Prev. Close 0.5999
Today's Range 0.5748 - 0.5998
52wk Range 0.5019 - 1.830
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Ainos Announces Successful Manufacturing of VELDONA GMP Clinical Batch by Swiss Pharmaceutical
Via ACCESSWIRE
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Pre-market stock movers are a hot topic on Wednesday as we check out all of the biggest movements happening this morning! 
Via InvestorPlace

Performance

YTD
-11.69%
-11.69%
1 Month
-3.38%
-3.38%
3 Month
-7.57%
-7.57%
6 Month
-16.68%
-16.68%
1 Year
-20.70%
-20.70%

More News

Read More
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Ainos Announces Positive Data Reported from its Clinical Studies for VELDONA as Potential Treatment of Oral Warts in HIV-Seropositive Patients, an Orphan Drug Designated by the FDA
Via ACCESSWIRE
Ainos Reports Third Quarter 2023 Financial Results
Via ACCESSWIRE
Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement
Via ACCESSWIRE
Ainos Commences Shipping its VELDONA Pet Cytoprotein Supplements in Taiwan
Via ACCESSWIRE
Ainos Reports Second Quarter 2023 Financial Results
Via ACCESSWIRE
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
With Orphan Drug Designation, Ainos' VELDONA Has Compelling Opportunity to Improve Quality of Life for HIV Patients
Via Newsfile
Ainos Celebrates First Listing Anniversary on Nasdaq
Via ACCESSWIRE
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Ainos’ VELDONA Granted Orphan Drug Designation by U.S. FDA for Potential Treatment of Oral Warts in HIV-Seropositive Patients
Via ACCESSWIRE
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Ainos, Inc - The AI Nose "Knows" What's Inside Your Body and Beyond
Via Newsfile
Topics Artificial Intelligence
Exposures Artificial Intelligence
Ainos Partners with Nisshinbo Micro Devices and Inabata to Co-Develop VOC Sensing Platform For Broader Industry Adoption
Via ACCESSWIRE
7 Healthcare Stocks to Ditch Before They Make Your Portfolio Sick
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Via InvestorPlace
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why State Street Shares Are Trading Lower By Over 10%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Dow Jumps 150 Points; JPMorgan Posts Upbeat Earnings
Via Benzinga
PLUG Stock Alert: Plug Power Pops on Analyst Upgrade
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.